Medicines Use Review (MUR)
Medicines Use Review (MUR)
The Medicines Use Review (MUR) and Prescription Intervention Service consists of accredited pharmacists undertaking structured adherence-centred reviews with patients on multiple medicines, particularly those receiving medicines for long-term conditions. National target groups have been agreed in order to guide the selection of patients to whom the service will be offered.
Changes to the targeting of MURs were agreed for implementation in 2014/15; further information is available in PSNC Briefing 016.14 Advanced Services (MURs and the NMS) and on the National target groups and Record keeping & data requirements pages.
Pharmacists and community pharmacy contractors practising in Wales should visit the Community Pharmacy Wales website for information on MURs in Wales.
Click on a heading below for more information.
Directions, Guidance and Service Specification
The legal basis for the service is provided by the Secretary of State Directions. The service specification provides a ‘plain English’ version of the Directions:
These Directions have been amended a number of times since publication. The amendment Directions are printed in the Drug Tariff. PSNC has created a document which consolidates the 2013 Directions and subsequent amendments made up to December 2016.
PSNC and NHS Employers guidance on MURs (updated guidance will be published to reflect the changes to MUR targets agreed in September 2014).
A list of suggested questions has been developed to help shape the discussion pharmacists have with patients during the MUR consultation. The use of the questions is not compulsory, but pharmacists may find them useful to obtain the maximum amount of information from the patient’s perspective as is possible.
PSNC Briefing 030/15: Services Factsheet – National Target Groups for MURs (June 2015)
Contractors must carry out at least 70% of their MURs within any given financial year on patients in one or more of the national target groups. This Briefing outlines the requirements for patients to fall into the different target groups.
PSNC Briefing 016/14: Advanced Services (MURs and the NMS) (September 2014)
This PSNC Briefing summarises the changes being made to the MUR service in 2014/15 and it covers the re-commissioning of the New Medicine Service (NMS).
PSNC Briefing 087/13: Advanced services and Pre-registration Trainees (20th August 2013)
Following media reports that pre-registration trainees have been allowed to provide MUR and NMS consultations without supervision by a pharmacist, PSNC has issued guidance to contractors.
Click on the links below for more information on that aspect of the service:
| MUR accreditation
| National target groups
| MUR patient consent
| MUR record keeping
| Communicating with GPs
| Working with hospital colleagues
| MURs v. Prescription Interventions
| Premises requirements
| Conducting MURs off the premises
| Advanced Services funding – MURs
| MUR statistics
| More MUR resources